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Abstract
Background: Addictive drugs have in common that they cause surges in dopamine (DA) concentration in the mesolimbic
reward system and elicit synaptic plasticity in DA neurons of the ventral tegmental area (VTA). Cocaine for example drives
insertion of GluA2-lacking AMPA receptors (AMPARs) at glutamatergic synapes in DA neurons. However it remains elusive
which molecular target of cocaine drives such AMPAR redistribution and whether other addictive drugs (morphine and
nicotine) cause similar changes through their effects on the mesolimbic DA system.
Methodology / Principal Findings: We used in vitro electrophysiological techniques in wild-type and transgenic mice to
observe the modulation of excitatory inputs onto DA neurons by addictive drugs. To observe AMPAR redistribution, post-
embedding immunohistochemistry for GluA2 AMPAR subunit was combined with electron microscopy. We also used a
double-floxed AAV virus expressing channelrhodopsin together with a DAT Cre mouse line to selectively express ChR2 in
VTA DA neurons. We find that in mice where the effect of cocaine on the dopamine transporter (DAT) is specifically blocked,
AMPAR redistribution was absent following administration of the drug. Furthermore, addictive drugs known to increase
dopamine levels cause a similar AMPAR redistribution. Finally, activating DA VTA neurons optogenetically is sufficient to
drive insertion of GluA2-lacking AMPARs, mimicking the changes observed after a single injection of morphine, nicotine or
cocaine.
Conclusions / Significance: We propose the mesolimbic dopamine system as a point of convergence at which addictive
drugs can alter neural circuits. We also show that direct activation of DA neurons is sufficient to drive AMPAR redistribution,
which may be a mechanism associated with early steps of non-substance related addictions.
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Introduction
The VTA, which is the origin of the mesolimbic DA system, has
been implicated in both the signaling of natural rewards and in the
formation of drug addiction. Much previous data has shown that
animals will readily self-administer electrical currents or addictive
drugs into the VTA [1]. However due to the non-specificity of
these interventions, it has been difficult to isolate the component
that initiates the reinforcing behavior, which may eventually lead
to addiction. Nevertheless, neurons of the VTA that release DA in
target regions including the nucleus accumbens (NAc) and the
prefrontal cortex as well as locally [2,3] appear to be centrally
involved.
Despite their diverse molecular targets, addictive drugs have in
common that they increase mesolimbic DA levels [4]. One of the
leading hypotheses posits that this surge in mesolimbic DA levels
triggers synaptic adaptations, first in the VTA, which may be
permissive for subsequent more general changes in other parts of
the brain. Such circuit reorganization may eventually cause
behavioral changes that underlie addiction.
According to the cellular mechanism engaged to increase DA
levels, addictive drugs have been classified into three groups [5].
Opioids, cannabinoids, benzodiazepines [6] and the club drug
gamma-hydroxybutyrate reduce transmitter release from inhibitory
afferents onto DA neurons, indirectly increasing the firing rate of
DA neurons, a mechanism defined as disinhibition. Nicotine, as a
member of the second group, directly depolarizes DA neurons by
activating alpha4beta 2-containing acetylcholine receptors, whereas
the third group, comprised of cocaine, ecstasy and amphetamines,
targets the DAT. Despite the observation that the representatives of
this third group decrease the firing frequency of the VTA neurons
[7,8] through D2 receptor mediated autoinhibition, extracellular
DA levels actually surge [9]. This is due the block of the reuptake of
the somato-dendritically released DA [10,11].
Drug-evoked synaptic plasticity in the VTA appears at
excitatory afferents onto DA neurons of the VTA already 24 h
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cocaine it is induced by D1/D5 receptor [14] and NMDAR
activation [12] and expressed in part by an insertion of GluA2-
lacking AMPARs [15]. When rendered persistent through
repetitive drug application, such adaptations in the VTA trigger
synaptic plasticity downstream in the NAc [16,17]. Several studies
have identified the effects of cocaine on the DA system as a key
contributor to its addictive properties. However, as cocaine also
inhibits serotonin and noradrenaline uptake, it is unknown
whether increased DA levels are crucial for cocaine-induced
AMPAR redistribution. If that is the case, other addictive drugs
should drive a similar receptor redistribution; even strong
activation of VTA DA neurons alone may be sufficient.
Here we show that mice with a cocaine-insensitive DAT lack
the redistribution of GluA2-lacking AMPARs following a single
injection of cocaine. Furthermore, we demonstrate that single
injections of addictive drugs with distinct mechanisms of action
lead to a redistribution of AMPARs. Finally, we show that selective
stimulation of DA VTA neurons at frequencies shown to increase
DA levels in target regions [3] using channelrhodopsin mimics the
AMPAR redistribution observed with addictive drugs.
Results
Cocaine-evoked AMPAR redistribution depends on DAT
inhibition
Cocaine is a non-selective monoamine reuptake inhibitor, and
has been shown to bind the serotonin, noradrenaline and
dopamine transporters with similar affinity [18]. To assess the
importance of the action of cocaine on the DAT for AMPAR
redistribution, we took advantage of a mouse line in which the
DAT is still able to take up endogenous DA but rendered
insensitive to cocaine (DATKI mouse, ref [19]. To validate this
approach we injected cocaine intraperitoneally (i.p.) whilst
recording from VTA neurons in vivo and observed an inhibition
in the in vivo firing rate of VTA neurons in WT mice but not in the
DATKI (Figure 1A, B). It is well established that the inhibition
observed in the WT mice is due to the activation of D2 receptors
present on the soma and dendrites of DA neurons. Nevertheless,
DA levels remain elevated in the VTA and the NAc [7,20] because
the blockade of the DAT by cocaine predominates [10].
We then recorded AMPAR-mediated EPSCs and plotted the
relative current–voltage (I–V)-relationship 24 h after a single
injection of saline or cocaine in WT and DATKI mice. In the
cocaine-treated DATKI mice, we found a linear I–V curve, similar
to saline-injected DATKI mice (Figure 1C). To quantify the inward
rectification, we calculated the rectification index (RI), which is the
ratio of the slope of the I–V curve at positive divided by the slope
at negative potentials. For GluA2-lacking AMPARs RI.1. This is
due to the specific polyamine-sensitivity that inhibits the current
flow at positive potentials [21]. As predicted from previous results,
RI was significantly higher in WT controls injected with cocaine,
reflecting the presence of GluA2-lacking AMPARs (Figure 1D).
This finding confirms that the insertion of GluA2-lacking
AMPARs is dependent on the inhibition of cocaine of the DAT.
Addictive drugs trigger AMPA receptor redistribution
Since these data suggest that the insertion of GluA2-lacking
AMPARs is dependent on the cocaine-evoked surge in DA, other
drugs known to increase DA levels could also drive this receptor
redistribution. Indeed a previous study observed that these drugs
can drive another form of synaptic change in the VTA [13]. We
therefore tested whether a single exposure to morphine or
nicotine, which increase DA in the mesolimbic system through
distinct mechanisms [5], also drives the insertion of GluA2-lacking
AMPARs. In such ex vivo slice recordings, we observed that the RI
was significantly higher after the exposure to an addictive
substance compared to saline-injected animals (Figure 2A, B).
To demonstrate that the synaptic insertion of GluA2-lacking
AMPARs occurred in exchange of native GluA2-containing
receptors, we directly visualized the GluA2 subunit with post-
embedding immunogold labeling at the electron microscopic level.
In slices from saline-treated mice the majority of GluA2 labeling
was observed at the synapse along with a small cytoplasmic pool.
In slices from morphine, nicotine and cocaine-exposed mice the
cytoplasmic GluA2 particles increased at the expense of the
synaptic staining (Figure 2C, D). As a control, labeling of PSD95
was always observed at synaptic locations (Figure 2E, F). Thus we
find that addictive drugs with diverse sites of action all can lead to
AMPAR redistribution. A common feature of all these drugs is
their ability to increase DA levels (either through increasing
neuron activity or blocking DA reuptake). If this point of
convergence is a critical component for the induction of AMPAR
redistribution, then selectively stimulating DA VTA neurons in the
absence of drugs should mimic this synaptic effect.
Selective stimulation of VTA DA neurons mimics drug-
driven AMPAR redistribution
To assess the ability of VTA DA neuron activation to induce
AMPAR redistribution, we virally expressed channelrhodopsin 2
(ChR2) selectively in DA neurons in vivo (stereotactic injection of
AAV2 vectors with ChR2 flanked by double loxP sites into the
VTA of DAT-Cre mice, see methods). We then lowered an optic
fiber, connected to a blue light solid-state laser (473 nm), to drive
action potentials in VTA DA neurons in vivo with brief pulses of
light. We observed that VTA DA neurons expressing ChR2 fired
action potentials immediately following five light pulses at 20 Hz
(Figure 3A–C), whilst non-DA VTA neurons exhibited no light-
evoked response (Figure 3D). This pattern of firing is similar to the
burst firing of DA neurons recorded during rewarding stimuli or
following administration of some addictive drugs [22,23,24]. Ex
vivo slice recordings confirmed the presence of ChR2-induced
photocurrents in DA neurons of DAT-Cre+ mice but not of non-
DA neurons (Figure 4A–C). Injected animals were then exposed to
an intermittent light stimulation protocol (Figure 5A. 5 pulses at
20 Hz each second) for 2 h. This duration mimics the time course
of increased DA levels observed with a single dose of cocaine or
nicotine [20,25]. In whole-cell recordings ex vivo one day after the
light simulation protocol, we obtained I-V curves from DA
neurons and found that the RI was significantly higher in slices
from DAT-Cre+ mice with respect to DAT-Cre2 controls
(Figure 5B, C). In a different set of experiments, we then applied
the above stimulation protocol immediately following an infusion
of SCH23390, a D1 receptor antagonist (Figure 5D). Under these
conditions the RI was significantly lower that in control
experiments where saline was infused (Figure 5E, F). Taken
together, these experiments show that a strong stimulation of DA
neurons, shown to efficiently release DA [3] and mimicking the
time course of the drug action is sufficient to drive AMPAR
redistribution at excitatory afferents onto DA neurons through a
D1 receptor-dependent mechanism.
Discussion
In the present study we show that the cocaine-driven
redistribution of AMPARs depends on its effect on the DAT.
We also show that morphine and nicotine, despite their distinct
cellular effects on the VTA, cause a similar synaptic adaptation.
Drugs and Dopamine Induce Synaptic Plasticity
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15870Figure 1. Cocaine drives the insertion of GluA2-lacking AMPARs via its effect on the DAT. (A) Single unit extracellular in vivo recordings
(above)andcorrespondingfiringrateplots(below)ofVTAneuronsduringasinglei.p.injectionof15 mg/kgcocaineineitherWT(left)orDATKI (right)mice.
Blackbardenotes injectiontime,(a)and(b)denotepoints fromwhichexampletracesweretaken.(B)Theresultinginhibitionofneuronfiringrateobserved
inWTmice(3863.3%)wasnotpresentinDATKI mice(94.961.4%). n=4–5, t(7)=16.5,p,0.0001.(C)RepresentativeAMPARexcitatorypostsynapticcurrents
recorded at 260, 0 and +30 mV (normalized to +40 mV AMPAR component) and RIs (D) of WT and DATKI mice 24 h post cocaine injection. Linearity
corresponds to and RI of 1. Mean RI=1.9560.17 in WT, and 1.1260.08 in DATKI;F (2–22)=9.8,p,0.001, n=5–9). All data are expressed as mean 6 sem.
doi:10.1371/journal.pone.0015870.g001
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PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15870Finally, in the absence of any pharmacological intervention, we
use optogenetic tools to selectively drive the activity of DA
neurons, and observe that this manipulation causes the AMPAR
redistribution. We conclude that, as with addictive drugs, selective
activation of the DA system is required to induce the insertion of
GluA2-lacking AMPARs.
The observation that the cocaine-induced AMPAR redistribu-
tion is dependent on the action of cocaine on the DAT
demonstrates that, despite the many other targets and actions of
cocaine, the increased DA levels following cocaine administration
are necessary for the AMPAR redistribution. Previous studies have
suggested that, in a mouse line with a constitutive DAT knockout,
Figure 3. Light pulses are sufficient to mimic burst firing of dopamine (DA) neurons in vivo. (A) Representative single unit recording
(above) and peristimulus time histogram (below, 5 ms bins) of a VTA DA neuron during a single light pulse (black markers; 4 ms, one sweep every
2 s) (n=7). (B) The same VTA DA neuron as in (A) responding to 5 light pulses at 20 Hz. (C) Light pulses (black markers) are sufficient to drive action
potentials, which do not differ in waveform characteristics from spontaneously occurring action potentials (above). Average percentage of action
potentials generated by consecutive light pulses (below). Note the decrease in fidelity of action potential firing with increasing numbers of light
pulses. (D) A GABAergic VTA neuron, which was recorded in close proximity to light-responsive DA neurons, exhibiting no response to five 4 ms light
pulses (n=7).
doi:10.1371/journal.pone.0015870.g003
Figure 2. Addictive drugs cause rectification via AMPAR redistribution. (A) Representative traces of AMPAR excitatory postsynaptic currents
recorded at 270, 0 and +40 mV. Examples are shown from recordings 24 h post injection. (B) Individual and averaged normalized rectification indices
(RIs) (mean 6 s.e.m) of saline and each drug treatment. RIs of morphine (2.1260.27), nicotine (2.0660.23) and cocaine (1.7260.14) groups were
significantly different from the saline (1.1260.08) control group (F(3,35)=4.93, p,0.01, ANOVA. n=7–15). (C) Representative electron micrographs of
VTA sections from saline- or drug-treated animals. Large profiles (arrows) represent tyrosine hydroxylase (TH) immunoreactivity in dendrites (Den)
forming asymmetrical synapses with boutons (b), and small profiles (arrowheads) represent GluA2 immunoreactivity. (D) Number of small profiles
plotted against the distance from the postsynaptic density. (E) Same as in (C) but staining against PSD 95. (F) Same quantification as in (D) but for
PSD 95.
doi:10.1371/journal.pone.0015870.g002
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the constitutive D1 receptor knockout mouse line showed no such
behavior [28]. These disparities may stem from significant
adaptive changes in a mouse in which the DAT is absent during
development. The DATKI mouse line, however, provides a model
in which the reuptake of dopamine is closer to the wild-type
condition (plus 64%), than in the DAT knockout [26,29], whilst
the action of cocaine on the DAT is severely impaired [30].
Figure 4. Expression of ChR2 causes light-activated currents in DA VTA neurons. (A) Representative whole cell voltage clamp recordings of
a DA VTA neuron. Following identification of cell type by the presence of an Ih current (left) responses to light pulses (black lines) at 4 ms (middle) or
100 ms (right) in the presence of TTX were tested (n=10). (B) Same as in (A) but a representative non-DA VTA neuron (note lack of Ih (left); n=6). (C)
Digital micrograph showing YFP labeling of neurons within the VTA, together with putative GABAergic unlabeled neurons (asterisks).
doi:10.1371/journal.pone.0015870.g004
Figure 5. In vivo stimulation of dopamine neurons is sufficient to drive AMPAR redistribution. (A) Protocol of light stimulation in vivo.( B)
Whole-cell voltage-clamp recordings made ex vivo 24 h post in vivo stimulation protocol. Representative traces of AMPAR excitatory postsynaptic
currents recorded at 260, 0 and +30 mV (below). (C) Individual and averaged normalized rectification indeces (RIs) (mean 6 s.e.m) following light
stimulation. RI of DAT Cre2=1.1260.14 (n=5). RI of DAT Cre+=2.4560.32 (n=5). p,0.01, Mann-Whitney U Test. (D) Protocol of intra-VTA infusion
and light stimulation in vivo,( E) Same as in (B) following intra-VTA infusion and light stimulation, (F) Same as in (C). RI of DAT-Cre+ saline
injected=1.7960.23 (n=4). RI of DAT Cre+ SCH23390 injected=0.9960.09 (n=5). p,0.05. Error bars represent s.e.m. Error bars are smaller than the
symbol for some data points.
doi:10.1371/journal.pone.0015870.g005
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conditioned place preference [30,31] , which confirms that block
of DA reuptake mediates reinforcing properties of the drug.
Moreover, in DATKI mice, compensatory adaptations seem not to
affect D2-like receptors [32], which may explain why we did not
observe any change in baseline synaptic transmission.
That other addictive drugs also cause increases in DA levels,
albeit through distinct mechanisms, presents an intriguing
convergence that may ultimately be responsible for their addictive
properties. Our finding that these addictive drugs also induce
AMPAR redistribution, backed up by data showing that another
synaptic change is common to these drugs [13], further implicates
a common mechanism. The current finding that a single injection
of nicotine can cause rectification has also recently been confirmed
by another group [33]. With the ChR2 we mimicked the activity
of drugs that can activate the DA neurons directly (e.g. nicotine) or
through disinhibition (e.g. morphine). While this shows that
selective DA neuron activation is sufficient to mimic drug-induced
AMPAR redistribution, other drug-specific mechanisms may
contribute. Cocaine for example, while actually causing a decrease
in DA neuron firing rate, is also able to induce AMPAR
redistribution. One possibility for this result is that the increased
dopamine concentration is responsible for the induction of this
plasticity. Our data suggest that DA signaling within the VTA is
driving AMPAR redistribution. First, other reports have used fast
scan voltammetry to show that similar optogenetic stimulation
protocols produce large DA transients in VTA target regions
[34,35,36]. Second, a previous study has shown that a change in
the AMPA/NMDA ratio, induced following administration of
addictive drugs, was blocked by application of a D1-like receptor
antagonist [37]. Our data with local VTA infusion of the same
antagonist confirms this requirement for D1 signaling. This
observation is also of interest in the context of recent evidence
that some DA neurons co-release glutamate [35,36].
Further experiments will have to establish the necessity of DA
neurons activation by inhibiting the DA neurons while giving a
drug or testing for occlusion if the effect of the stimulation after
drug exposure.
Since previous pharmacological [12] and genetic [38] manip-
ulations also demonstrated the need for NMDARs on DA
neurons, intrinsic glutamatergic transmission may also be required
and future studies will have to identify the locus and hierarchy of
the convergence of DA- and NMDA-signaling. As drug-triggered
AMPAR redistribution has also been induced in a VTA slice
preparation, this implies a mechanism restricted to the circuitry
within the VTA [37]. Indeed, bursting of DA neurons is also
particularly efficient at driving DA release within the VTA [3,2].
However, whether or not reciprocal connections between
glutamatergic or GABAergic nuclei and DA VTA neurons were
potentiated with this protocol cannot be ruled out. Indeed it is
possible that adaptations in the NAc may have an indirect effect
on the VTA via the strong back-projection of this nucleus to the
midbrain [39].
A previous report has shown that stimulation of DA neurons,
albeit with a different protocol, leads to behavioral conditioning,
such as conditioned place preference (CPP, [34]. This provides
evidence that increasing DA neuron activity could be sufficient to
drive this behavioral response, and so represents a reinforcing
stimulus [40,41]. However the relationship between mesolimbic
DA, synaptic plasticity and behavior is complex. Earlier reports
suggest that CPP can be observed with morphine in mice that lack
efficient DA synthesis [42]. Moreover the cellular changes were
not investigated in these studies. In an inducible, conditional
mouse line lacking NMDARs in DA neurons, the insertion of
GluA2-lacking AMPARs and conditioned place preference were
dissociated. Cocaine-evoked unbiased CPP was not affected (but
see[43] for results with a biased protocol) in the NMDAR-mutant
mice where AMPAR redistribution was absent. However these
mice did show reduced reinstatement [38] and cue-induced
cocaine seeking [16]. Our finding that selective stimulation of DA
VTA neurons leads to AMPAR redistribution therefore provides
strong evidence that increased DA neuron activity is capable of
modifying the network at the synaptic level.
Given that addictive drugs are chemically very diverse and each
has a distinct molecular target, it is surprising that they induce
symptoms that are indistinguishable. Our study provides proof of
principle for an early point of convergence in the function of the
DA neurons of the VTA. The release of mesolimbic DA seems
critical for the induction of a form of synaptic plasticity that
predicts long-term adaptations in the neural reward circuits. The
fact that we were able to elicit AMPAR redistribution with passive
drug administration or passive light-activation indicates the
permissive nature of these events for addiction.
We believe that by proposing a site of initiation for the final
common pathway, future research may lead to an unifying model
including non-substance dependent addictions to gain further
mechanistic insight, and propose rational therapies.
Materials and Methods
Ethics Statement
All experiments were carried out in accordance with the
Institutional Animal Care and Use Committee of the University of
Geneva and with permission of the cantonal authorities (Permit
No. 1007/3592/2).
Subjects. Experimental procedures were conducted in C57/
BL6, DATKI [19] and DAT-Cre [44] mice. Mice were house
together except for those implanted with guide cannulae, which
were housed separately.
Intraperitoneal (i.p.) injections in mice
C57/BL6 or DATKI mice (P14–21, 8–11g bodyweight) were
injected i.p. with cocaine (15 mg/kg), morphine (15 mg/kg),
nicotine (0.5 mg/kg) or 0.9% saline with a 26G hypodermic
needle to minimize stress.
Stereotactic injection of ChR2-AAV
Injections of AAV-ChR2 [34] produced at the University of
North Carolina (Vector Core Facility) were made in 7–9 g DAT-
Cre mice for ex vivo experiments, and 15–20g mice for in vivo
electrophysiological recordings and in vivo light stimulation.
Anesthesia was induced and maintained with isoflurane (Baxter
AG, Veinna, Austria). The animal was placed in a stereotaxic
frame (Angle One; Leica, Germany) and craniotomies were
performed over the VTA either unilaterally (for in vivo recordings
and in vivo light stimulation) or bilaterally (for ex vivo experiments)
using stereotaxic coordinates (AP 23.3, ML 61.3, DV 4.4, 10u
angle). Injections of AAV-ChR2 were carried out using graduated
pipettes (Drummond Scientific Company, Broomall, PA), broken
back to a tip diameter of 10–15 mm, at a rate of ,1 ml/min. In all
experiments the virus was allowed a minimum of 12 days to
incubate before any other procedures were carried out.
Cannula implantation
Following anesthesia and completion of the craniotomy (see
above), three holes were drilled around the craniotomy into which
screws were placed. After virus injections (see above), a guide
cannula (Plastics One, Roanoke, VA) was lowered slowly into
Drugs and Dopamine Induce Synaptic Plasticity
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cemented in place using dental cement (Lang Dental MFG
Company, Wheeling, IL) to encase the base of the guide cannula
and the screws. Once the cement had dried, a dummy cannula
(Plastics One) was placed inside the guide cannula to prevent
infection.
Slice electrophysiology
Horizontal 200–250 mm slices of mouse midbrain were
prepared in cooled artificial cerebrospinal fluid (ACSF) containing
(in mM) NaCl 119, KCl 2.5, MgCl 1.3, CaCl2 2.5, Na2HPO4 1.0,
NaHCO3 26.2 and glucose 11, bubbled with 95% O2 and 5%
CO2. In older mice in which cannulation and in vivo light
stimulation had been performed, slices were prepared in ACSF as
above with the addition of (in mM) kynurenic acid 3, NaHCO3,
sucrose 225, glucose 1.25 and MgCl2 4.9. Slices were kept at 34uC
for 1 h before being transferred to the recording chamber
superfused with 2.5 ml min
21 ACSF. Visualized whole-cell
voltage-clamp recording techniques were used to measure holding
currents from neurons of the VTA, identified as the region medial
to the medial terminal nucleus of the accessory optic tract. Where
possible, DA neurons were identified by presence of a large Ih
immediately after entering whole-cell configuration. For experi-
ments in which AMPAR EPSCs and photocurrents were
recorded, the internal solution contained (in mM) CsCl 130,
NaCl 4, MgCl2 2, EGTA 1.1, HEPES 5, Na2ATP 2, sodium
creatine-phosphate 5, Na3GTP 0.6 and spermine 0.1. For
experiments in which only photocurrents were recorded, the
internal solution contained (in mM) potassium gluconate 130,
MgCl2 4, creatine phosphate 10, Na2 ATP 3.4, Na3 GTP 0.1,
EGTA 1.1, HEPES 5. Traces were amplified, filtered at 5 kHz
and digitized at 20 kHz. The liquid junction potential was small
and so traces were not corrected. All experiments measuring the I–
V relationship were carried out in the presence of picrotoxin
(100 mM) and D,L-APV (100 mM) in order to block GABAA and
NMDA receptors, respectively. The holding potentials were 260/
270 mV, 0 mV and +30/+40 mV, and the access resistance was
monitored by a hyperpolarizing step of 210 mV with each sweep,
every 10 s. Experiments were discarded if the access resistance
varied by more than 20%. Synaptic currents were evoked by
stimuli (0.04–0.1 ms) at 0.1 Hz through bipolar stainless steel
electrodes placed rostral to the VTA. The rectification was
calculated by dividing the gradient of the slope at negative
potentials by the gradient of the slope at positive potentials.
Simultaneous in vivo electrophysiological recordings and
light stimulation
Anesthesia was induced with choral hydrate (4% w/v, 480 mg/
kg i.p.) and maintained with supplemental doses as required (4%
w/v, 120 mg/kg i.p.). All wound margins were infiltrated with
lidocaine (4%), and corneal dehydration was prevented with
Viscotears (Novartis; Basel, Switzerland). Mice were placed into a
stereotaxic frame (Angle One) and their temperature was
maintained using a homeothermic heating blanket (Harvard
Apparatus, Holliston, MA). Anesthesia was continually monitored
by testing reflexes to gentle corneal stimulation and a cutaneous
pinch.
A craniotomy was performed to expose the cortex overlying the
left VTA, of a size large enough to accommodate the guide
cannula and the recording electrode. The cannula was sterotaxi-
cally positioned and slowly lowered vertically into position at the
dorsal boundary of the VTA. Dental cement (Lang Dental) was
used to secure the cannula whilst taking care not to allow cement
to cover the craniotomy. A fiber optic cable (Thorlabs, Munich,
Germany) was then lowered through the guide cannula so that
,50 mm of fiber protruded from the guide cannula, and attached
to a 473 nm solid-state laser (Crystalaser, Reno, NV). Extracellular
recordings of action potentials were made using a glass recording
electrode with a tip diameter of ,1–2 mm, filled with a saline
solution (0.5M NaCl) containing Chicago Sky Blue dye (2% w/v)
and lowered into the VTA at a 10u angle. A reference electrode
was placed in the subcutaneous tissue. Electrical signals were AC-
coupled, amplified (Neurodata IR 183; Neurodata Instruments
Corp., New York, NY), and monitored in real time using an
audiomonitor (custom made). Any 50 Hz noise was eliminated
using a Humbug (Quest Scientific, Vancouver, Canada). Signals
were digitized at 20 kHz (for waveform analysis) or 5 kHz and
stored on hard disk using a custom-made program within IGOR
(WaveMetrics, Lake Oswego, OR). The bandpass filter was set
between 0.3 and 5 kHz. Action potentials always exhibited an
initial positive deflection. The laser was controlled using the Igor
program via a TTL box. Following electrophysiological record-
ings, Chicago Sky blue dye was iontophoretically injected into the
recording site (Stoelting, Wood Dale, IL) for confirmation that the
recordings were made within the VTA. Dopaminergic VTA
neurons were identified based on their established electrophysio-
logical properties. These criteria included a biphasic action
potential $1.1 ms [45], and slow regular-irregular firing [46,47].
In vivo stimulation of VTA DA neurons
Virus-injected and cannulated animals were allowed a mini-
mum of 12 days to recover, and for the virus to express in VTA
DA neurons. The same solid-state laser used for in vivo
electrophysiological recordings was used to carry out the in vivo
stimulation protocol in awake mice. In a subset of experiments, an
infusion of 0.25mg of SCH23390 into the VTA through the guide
cannula in 0.9% ml NaCl just prior to light stimulation. A fiber
optic cable (Thorlabs) was customized to enable the mouse to
move freely during stimulation. Briefly, the plastic cap of a dummy
cannula (Plastics One) was hollowed out and a hole of sufficient
diameter for the fiber optic to pass through made in the top. This
was threaded onto the fiber optic, one end of which was stripped
to leave a 120 mm external diameter. The plastic portion of an
internal cannula (Plastics One) was glued onto the fiber optic
leaving enough fiber to reach the bottom of the guide cannula.
The fiber was then lowered into the guide cannula on the mouse,
and the hollowed-out dummy cannula cap screwed onto the guide
cannula. This allowed the fiber optic to turn freely throughout the
stimulation protocol, whilst ensuring a constant length of the fiber
remained within the guide cannula. The fiber was connected to
the laser, which delivered five 4 ms pulses per second at 20 Hz for
2 hours (controlled using a Master 8 (A.M.P.I.)). All stimulations
were carried out in a controlled environment.
Post-embedding immunohistochemistry
Slices of the VTA from saline- and drug-treated mice were cut
at 500 mm and immersed in 4% paraformaldehyde, 0.1%
glutaraldehyde and ,0.2% picric acid made up in 0.1 M
phosphate buffer (PB; pH 7.4) for 6 hours. Slices were incubated
in 1 M sucrose/PBS solution overnight, slammed onto copper
blocks cooled in liquid nitrogen and processed for osmium-free
embedding. Briefly, slices were incubated for 40 minutes in 1%
uranyl acetate, dehydrated in methanol and embedded in Unicryl
resin (Electron Microscopic Sciences, PA, USA). Ultrathin sections
(70–90 nm) from Unicryl-embedded blocks were incubated for
45 min on pioloform-coated nickel grids with drops of blocking
solution consisting of 2% albumin in 0.05 M TBS, 0.9% NaCl,
and 0.03% Triton X-100. The grids were transferred to solutions
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concentration of 10 mg/ml diluted in blocking solution overnight
at room temperature. After several washes in TBS, grids were
incubated for 2 h in drops of goat anti-mouse IgG and goat anti-
rabbit IgG conjugated to 10 nm colloidal gold particles and
20 nm-colloidal gold particles, respectively (BioCell International,
Cardiff, UK), each diluted 1:80 in a 0.05 M TBS solution
containing 2% normal human serum and 0.5% polyethylene
glycol. Grids were then washed in TBS for 30 min and
counterstained for electron microscopy with saturated aqueous
uranyl acetate and lead citrate. Ultrastructural analyses were
performed in a Jeol-1010 electron microscope.
Statistical analyses
Compiled data are expressed as mean 6 s.e.m. The level of
significance was set at p=0.05 as determined by the non-
parametric Mann-Whitney U Test or the one-way ANOVA with
Dunnett post-test.
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